Total Intravenous Anesthesia (TIVA)/Sevoflurane Initiated Intravenous Anesthesia (SIIVA) in Pediatric Patients

ConditionExtubation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 9
SponsorWake Forest University Health Sciences

About this trial

Because Propofol is the primary "anesthetic agent," and inhalational agents remain in trace quantities at the end of the procedure Sevoflurane initiated intravenous anesthesia (SIIVA) or not present at all Total intravenous anesthesia (TIVA) it is likely that different criteria may be predictive of extubation success in these patients compared to inhalational anesthesia.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Pediatric patients <10 years of age

Undergoing elective or emergency surgery with planned airway instrumentation with an endotracheal tube (ETT)

Patients having general anesthesia with a planned SIIVA or TIVA technique

Patients with an end tidal agent concentration of Sevoflurane<0.1% at the time of emergence and extubation

Disqualifiers

History of home oxygen use or ventilator dependence

Patients with cyanotic congenital heart disease

Patients undergoing anesthesia for imaging procedures alone

Patients intended to be managed with supraglottic airway

Trial population

All study participants must be \< 10 years of age and undergoing general anesthesia and surgery with an endotracheal tube and using a SIIVA or TIVA approach

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Total intravenous anesthesia (TIVA)

    Other intervention

    TIVA anesthetic -no inhalational gases for surgery

  • Sevoflurane initiated intravenous anesthesia (SIIVA)

    Other intervention

    SIIVA - sevoflurane anesthetic gases for surgery

Treatment groups

600 Participants
are divided into 2 treatment groups
Group A: Total intravenous anesthesia (TIVA)1 intervention
Group B: Sevoflurane initiated intravenous anesthesia (SIIVA)1 intervention

Trial outcomes

Primary outcomes

1

Extubation success rate

quality of extubation will be assess using a standard rubric for all extubation

Time frame
Day 1

Secondary outcomes

1

Rate of extubation that requiring intervention

desaturation, laryngospasm, airway obstruction or other issues

Time frame
Day 1

Other outcomes

1

Number of Subjects that met specific extubation criteria

Assess the presence of specific extubation criteria met during the extubation

Time frame
Day 1

Sponsors and contacts

Click on the lead sponsor to view all of their trials.